UMIN-ICDS History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000049032 |
|---|---|
| Receipt number | R000055365 |
| Scientific Title | Retrospective cohort study to evaluate the efficacy and safety of trastuzumab deruxtecan in patients with HER2-positive unresectable advanced or recurrent gastric cancer |
| Date of disclosure of the study information | 2022/10/12 |
| Last modified on | 2024/03/28 11:47:12 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2022/09/27 11:06:48 | ||
| 2 | Update | 2022/09/27 11:16:20 | Address |
|
| 3 | Update | 2022/09/27 17:32:55 | Anticipated trial start date |
|
| 4 | Update | 2022/09/27 17:34:24 | Date of disclosure of the study information |
|
| 5 | Update | 2022/10/11 14:34:33 | Anticipated trial start date |
|
| 6 | Update | 2022/10/17 16:49:04 | Anticipated trial start date |
|
| 7 | Update | 2022/10/25 19:27:01 | Anticipated trial start date |
|
| 8 | Update | 2022/10/25 19:30:51 | Institutions |
|
| 9 | Update | 2022/10/25 19:32:04 | Date of IRB |
|
| 10 | Update | 2022/10/28 19:44:48 | Anticipated trial start date |
|
| 11 | Update | 2022/10/31 17:38:48 | Recruitment status Date of IRB |
|
| 12 | Update | 2023/09/26 16:23:34 | Date of closure to data entry |
|
| 13 | Update | 2023/09/26 19:32:46 | Recruitment status Date trial data considered complete Date analysis concluded |
|
| 14 | Update | 2024/03/28 11:47:12 | Recruitment status |
